New York State Common Retirement Fund Agenus Inc Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$0.53 - $0.93 $19,437 - $34,107	36,675 Added 478.85%	44,334 $26,000
Q4 2023 Feb 01, 2024	SELL	$0.63 - $1.14 $76,313 - $138,090	-121,132 Reduced 94.05%	7,659 $6,000
Q3 2023 Nov 07, 2023	BUY	$1.12 - $1.88 $1,704 - $2,861	1,522 Added 1.2%	128,791 $146,000
Q2 2023 Aug 07, 2023	SELL	$1.31 - $2.04 $5,752 - $8,957	-4,391 Reduced 3.34%	127,269 $204,000
Q1 2023 May 02, 2023	SELL	$1.45 - $2.95 $83,034 - $168,931	-57,265 Reduced 30.31%	131,660 $200,000
Q4 2022 Jan 30, 2023	BUY	$2.02 - $3.25 $12 - $19	6 Added 0.0%	188,925 $453,000
Q3 2022 Nov 08, 2022	BUY	$1.96 - $3.14 $1,593 - $2,552	813 Added 0.43%	188,919 $387,000
Q2 2022 Aug 04, 2022	BUY	$1.3 - $2.64 $66,474 - $134,993	51,134 Added 37.33%	188,106 $365,000
Q1 2022 May 05, 2022	SELL	$2.35 - $3.47 $96 - $142	-41 Reduced 0.03%	136,972 $337,000
Q4 2021 Feb 02, 2022	BUY	$2.92 - $5.74 $26 - $51	9 Added 0.01%	137,013 $441,000
Q3 2021 Nov 02, 2021	SELL	$4.98 - $6.63 $165,365 - $220,155	-33,206 Reduced 19.51%	137,004 $719,000
Q2 2021 Aug 02, 2021	BUY	$2.56 - $5.49 $111,129 - $238,320	43,410 Added 34.24%	170,210 $934,000
Q2 2020 Aug 07, 2020	BUY	$2.29 - $4.24 $81,753 - $151,368	35,700 Added 39.19%	126,800 $498,000
Q4 2019 Feb 05, 2020	SELL	$2.41 - $4.4 $44,826 - $81,840	-18,600 Reduced 16.96%	91,100 $371,000
Q3 2019 Nov 07, 2019	BUY	$2.17 - $3.14 $5,859 - $8,478	2,700 Added 2.52%	109,700 $283,000
Q2 2019 Aug 09, 2019	BUY	$2.53 - $3.04 $94,621 - $113,696	37,400 Added 53.74%	107,000 $321,000
Q2 2017 Aug 11, 2017	BUY	N/A	69,600	69,600 $272,000

Others Institutions Holding AGEN

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account